Project Grant R01DK147593
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $350,902 Project Grant to the University of California, Irvine on July 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award supports a surgeon-scientist candidate's research and career development focused on investigating urethral dysfunction in female urinary incontinence (UI). The research addresses a significant...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $2.56 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 1, 2025, with a completion date of August 31, 2029. This four-year research initiative investigates the neurobiological mechanisms by which animals learn to associate flavors with...
- Federal Grant Award Summary The University of California, San Francisco received a $2.78 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective September 15, 2025, through September 14, 2029. The research deliverables focus on advancing understanding of Hirschsprung Disease (HSCR), a severe congenital gastrointestinal disorder characterized by the...
- Federal Grant Award Summary The University of California, San Francisco received a $1,475,898 Project Grant award dated September 24, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds research through June 30, 2030, to modernize clinical assessment methods for fluid management in hemodialysis patients with end-stage kidney disease (ESKD). The project will...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) was awarded $3,140,632 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a four-year project period from September 1, 2025, through August 31, 2029. This Project Grant supports fundamental biomedical research focused on elucidating the mechanisms of human endocrine lineage commitment...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1.835 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 1, 2025, with a completion date of May 31, 2030. This award supports the UCSF Type 1 Diabetes Research Center (DRC), a cross-departmental basic and clinical research enterprise that...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $451,000 to the University of California, San Francisco on September 5, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a 24-month research project extending through August 31, 2027. This Project Grant funds investigator-initiated biomedical research examining the role of microRNAs (miRNAs) in adipose tissue...
- Federal Project Grant Award Summary The University of California, San Francisco received a $2.97 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 4, 2025, with completion targeted for August 31, 2029. This research award funds translational investigations into how fatty acids regulate protein synthesis and metabolic reprogramming...
- Federal Project Grant Award Summary The University of California, San Francisco received a $3.18 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on September 15, 2025, with completion targeted for September 14, 2029. This four-year research initiative investigates the role of the macrophage scavenger receptor MARCO (macrophage receptor with...
- Federal Grant Award Summary The University of Nevada, Reno received a $2.56 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, through September 14, 2029. This award supports basic biomedical research investigating novel regulatory mechanisms of gastrointestinal (GI) motility through the study of GI hormones and...
The University of California, San Francisco received a $512,595 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 15, 2026, with completion targeted for February 28, 2030. This award funds basic biomedical research investigating a novel neural circuit mechanism that regulates urinary and fecal continence, with the ultimate objective of developing translatable therapeutic strategies for treating incontinence disorders. The research leverages mouse models to elucidate how estrogen-responsive neurons in the hypothalamus communicate with the pontine micturition center in the hindbrain to modulate bladder and colon function, potentially informing future clinical interventions for age-related incontinence. The project delivers three coordinated research activities: identifying molecular components of inhibitory neurons and their projections to the spinal cord; determining the sufficiency of hypothalamic-hindbrain neural circuit components in controlling urine release; and characterizing the initiating signals in the hypothalamus that regulate voiding and defecation. These investigator-initiated research activities advance the scientific understanding of brain-body physiology mechanisms underlying continence control and contribute to NIDDK's mission to improve prevention, diagnosis, and treatment of kidney and digestive diseases through extramural basic and clinical biomedical research conducted at the San Francisco, California facility.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $512.6k | 4/13/26 |